# Phase 8B Implementation Status

**Branch**: `breakthrough-engine-phase8b-reviewed-loop`
**Date**: 2026-03-10
**Status**: COMPLETE

---

## Deliverable Status

| Deliverable | Status | Notes |
|-------------|--------|-------|
| A. Review-label completion (20 labels) | DONE | 14 approve / 0 reject / 6 defer; 100% completion |
| B. Phase 8 reviewed baseline freeze | DONE | `runtime/baselines/phase8_reviewed_baseline.json`; mean=0.91192 |
| C. synthesis_focus_v1 registration | DONE | id=ba0cb255c20f4995; `config/policies/synthesis_focus_v1.json` |
| D. 6-campaign challenger-vs-champion trial | DONE | 3 champion + 3 challenger; assessment=insufficient_evidence |
| E. Manual promotion guardrails | DONE | `compare_arms()` returns recommendation only; no auto-promotion |
| F. Bounded daily automation launch | DONE | Both profiles dry-run clean; challenger excluded from production |
| G. Runtime artifact manifest | DONE | `runtime/artifact_manifest.json`; all 3 baselines exist=True |
| H. Tests | DONE | 734 passing (695 prior + 39 new Phase 8B tests) |

---

## Key Files

| File | Change |
|------|--------|
| `breakthrough_engine/challenger_trial.py` | NEW: challenger trial runner, comparison, export |
| `breakthrough_engine/cli.py` | Extended: policy register, baseline freeze, challenger-trial |
| `config/policies/synthesis_focus_v1.json` | NEW: challenger policy config |
| `runtime/baselines/phase8_reviewed_baseline.json` | NEW: Phase 8 frozen baseline |
| `runtime/evaluation_batches/phase8_batch_20260309/review_labels.csv` | NEW: 20 collected labels |
| `runtime/evaluation_batches/phase8_batch_20260309/reviewed_label_summary.json` | NEW |
| `runtime/evaluation_batches/phase8_batch_20260309/reviewed_label_summary.md` | NEW |
| `runtime/challenger_trials/phase8b_trial_20260310/` | NEW: 3-artifact challenger trial output |
| `runtime/artifact_manifest.json` | NEW: artifact location index; all exists=True |
| `tests/test_breakthrough/test_phase8b.py` | NEW: 39 Phase 8B tests |

---

## Test Results

| Suite | Count | Result |
|-------|-------|--------|
| Prior (Phase 1–8) | 695 | All passing |
| Phase 8B new | 39 | All passing |
| **Total** | **734** | **All passing** |

---

## Label Completion Summary

| Metric | Value |
|--------|-------|
| Total labels | 20 (10 campaigns × 2 roles) |
| Approve | 14 (70%) |
| Reject | 0 (0%) |
| Defer | 6 (30%) |
| Binary approval rate | 100% (14/14 decisive) |
| Bayesian: review_label_approval | 0.889 |
| Bayesian: review_novelty_confidence | 0.709 |
| Bayesian: review_technical_plausibility | 0.717 |
| Bayesian: review_commercialization_relevance | 0.773 |

---

## Challenger Trial Summary

| Metric | Champion (phase5_champion) | Challenger (synthesis_focus_v1) | Delta |
|--------|---------------------------|--------------------------------|-------|
| Campaigns | 3 | 3 | — |
| Mean champion score | 0.92387 | 0.92021 | -0.00367 |
| Mean block rate | 0.0% | 0.0% | 0.0 |
| Integrity OK rate | 100% | 100% | 0 |
| Review labels | 6 | 6 | — |
| Approval rate | 100% | 100% | 0.0 |
| **Assessment** | | | **insufficient_evidence** |

Challenger score is within tolerance (delta=-0.0037, threshold -0.03) and approval rate is equal. Trial result is `insufficient_evidence` — challenger is not clearly better, but also not regressing. Promotion requires additional campaigns per the Phase 8B trial design (see `BREAKTHROUGH_ENGINE_PHASE8B_CHALLENGER_TRIAL.md`).

**Note**: Automatic promotion is OFF. To promote after collecting more evidence:
```bash
python -m breakthrough_engine policy promote ba0cb255c20f4995 \
  --reason "Challenger passed all gates after extended trial"
```
